Poster Abstract Session:
230. Clostridium difficile: Epidemiology
Saturday, October 29, 2016: 12:30 PM-2:00 PM
Room: Poster Hall

Learning Objectives:


Tracks: Epidemiology and Infection Control, Adult ID

Comparison of Pulsed-Field Gel Electrophoresis and Whole Genome Sequencing in Clostridium difficile Typing
Ling Yuan Kong, MD ; David Eyre, BM BCh DPhil MCRP FRCPath ; A. Sarah Walker, PhD ; Jacques Corbeil, PhD ; Mark Wilcox, MD ; Anne-Marie Bourgault, MD ; Andre Dascal, MD ; Matthew Oughton, MD ; Sophie Michaud, MD, MPH ; Baldwin Toye, MD ; Eric Frost, PhD ; Louise Poirier, MD, FRCPC ; Paul Brassard, MD ; Nathalie Turgeon, MD ; Rodica Gilca, MD PhD ; Vivian Loo, MD, MSc, FSHEA
  • Poster 201610 final.pdf (349.2 kB)
  • Use of a State Health Information Exchange for Public Health Clostridium difficile Surveillance Case Investigations
    Rebecca Perlmutter, MPH ; Katherine Richards, MPH ; Lucy Wilson, MD, ScM ; David Blythe, MD, MPH
    The effect of a piperacillin/tazobactam shortage on antimicrobial prescribing and hospital-onset Clostridium difficile infection rates in 88 U.S. medical centers
    Alan E. Gross, PharmD, BCPS-AQ ID ; Vikas Gupta, Pharm.D., BCPS ; Susan C. Bleasdale, MD ; Ying P. Tabak, PhD ; Richard S Johannes, MD, MS
    Change in Distribution of Clostridium difficile NAP1 Strain in Patient Population in the North Suburbs of Chicago.
    Elena Usacheva, Ph.D. ; Donna Schora, MT(ASCP) ; Becky Smith, MD ; Lance Peterson, MD, FIDSA, FSHEA
    Clostridium difficile in an Urban, University-Affiliated LTACH
    Jerry Jacob, MD ; Jingwei Wu, PhD ; Jennifer Han, MD, MSCE ; Deborah Nelson, PhD
  • IDweek Poster_2.pdf (2.2 MB)
  • Burden of Clostridium difficile infection (CDI) across hospital inpatient, nursing home, and home settings
    Anita Sung, PhD ; Omneya Mohamed, PhD ; Li Wang, MA, PhD, MBA ; Stephen Marcella, MD, MPH
    Epidemiology of Clostridium difficile infections in Japan
    Hitoshi Honda, MD, PhD ; Erik R. Dubberke, MD, MSPH, FIDSA, FSHEA ; Tadashi Fukuda, PhD ; Mitsutoshi Senoh, PhD ; Kimberly Reske, MPH ; Margaret Olsen, PhD, MPH ; Yasuaki Tagashira, MD ; Haru Kato, MD PhD
    Clinical and epidemiological description of diarrheal episodes caused by Clostridium difficile RT027 in Mexico.
    Karla María Tamez-Torres, MD ; Pedro Torres-González, MD ; Miguel Enrique Cervera-Hernández, MD ; Norma Irene López-García, BSc ; Eva Plascencia-Morán, MD ; Miriam Bobadilla-Del Valle, PhD ; José Sifuentes-Osornio, MD, FIDSA ; Alfredo Ponce De León, MD
    Prevalence of Clostridium difficile ribotypes in Minnesota, 2012-2014
    Dominic Sandmeier Jr., BS ; Tory Whitten, MPH ; Maria S. Karlsson, PhD ; Stacy Holzbauer, DVM, MPH, DACVPM
  • PrevalencePoster_Final.pdf (303.5 kB)
  • Does Timing Matter?: Comparing Rates of Clostridium difficile Colonization Among Community Onset and Hospital Onset Inpatients
    Tina Wang, MD ; Michele Yeung, MD ; Daniel Luger, MD ; Marcelo Mendez, MD ; Marie Moss, RN, MPH, CIC ; Dana Mazo, MD, MSc
  • Cdiff Poster IDSA FINAL.pdf (215.8 kB)
  • Increasing Incidence of Community-Acquired Clostridium difficile Infections Among Hospitalized Patients
    Sarah S. Lewis, MD MPH ; Arthur W. Baker, MD, MPH ; Rebekah W. Moehring, MD, MPH ; Daniel Sexton, MD ; Deverick Anderson, MD, MPH, FIDSA, FSHEA
    A population-based longitudinal study of Clostridium difficile infection-related hospitalization in mid-age and older adults
    Yingxi Chen, BM, MPH(Res) ; Kathryn Glass, PhD ; Bette Liu, PhD ; Thomas Riley, MAppEpid, PhD, FASM, FAAM, FRCPath, FFSc(RCPA) ; Rosemary Korda, PhD ; Martyn Kirk, PhD
  • CDI.pdf (647.2 kB)
  • Clostridium difficile in Pediatric Oncology Patients
    Elizabeth Robilotti, MD MPH ; Jennifer Brite, MPH ; Anoshe Aslam, MPH ; Mini Kamboj, MD

    CME Credits: No CME credit is offered for this session.

    ACPE Credits:

    ACPE Number:

    Findings in the abstracts are embargoed until 12:01 a.m. CDT, Wednesday Oct. 26th with the exception of research findings presented at the IDWeek press conferences.